Also trades as: MVP.AX (ASX) · $vol 0M
MDDVF OTC
Medical Developments International Limited
1W: +0.0%
1M: -5.1%
3M: -14.2%
YTD: +4.5%
1Y: -1.0%
3Y: -39.9%
5Y: -93.7%
$0.32
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$43M
+8.8% ▲
5Y CAGR: +11.0%
Gross Profit
$12M
-59.3% ▼
5Y CAGR: -6.4%
Operating Income
$1M
-65.7% ▼
Net Income
$625K
+565.0% ▲
EPS (Diluted)
$0.01
+562.5% ▲
EBITDA
$4M
+123.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $22M | $32M | $33M | $39M | $43M |
| YoY Growth | -13.2% | +47.4% | +2.5% | +17.8% | +8.8% |
| Cost of Revenue | $25M | $35M | $9M | $10M | $31M |
| Gross Profit | -$3M | -$3M | $24M | $29M | $12M |
| Gross Margin | -13.9% | -7.8% | 73.5% | 75.3% | 28.1% |
| R&D Expenses | $220K | $236K | $313K | $271K | $0 |
| SG&A Expenses | $25M | $36M | $35M | $26M | $11M |
| Operating Expenses | $13M | $18M | $35M | $26M | $11M |
| Operating Income | -$16M | -$14M | -$11M | $3M | $1M |
| Operating Margin | -71.5% | -44.6% | -33.3% | 7.9% | 2.5% |
| Interest Expense | $103K | $95K | $86K | $0 | $65K |
| Income Before Tax | -$16M | -$7M | -$33M | $168K | $503K |
| Tax Expense | -$4M | -$2M | $8M | $74K | -$122K |
| Net Income | -$12M | -$6M | -$41M | $94K | $625K |
| Net Margin | -56.5% | -17.3% | -123.7% | 0.2% | 1.5% |
| EPS (Diluted) | $-0.17 | $-0.07 | $-0.47 | $0.00 | $0.01 |
| EBITDA | -$13M | -$4M | -$29M | $2M | $4M |
| Shares Outstanding | 72M | 84M | 86M | 112M | 117M |